Folgen
Marco Tuccori
Marco Tuccori
Associate Professor of Pharmacology - University of Verona
Bestätigte E-Mail-Adresse bei univr.it
Titel
Zitiert von
Zitiert von
Jahr
Pioglitazone use and risk of bladder cancer: population based cohort study
M Tuccori, KB Filion, H Yin, HY Oriana, RW Platt, L Azoulay
bmj 352, 2016
2672016
Monoclonal antibody therapies against SARS-CoV-2
D Focosi, S McConnell, A Casadevall, E Cappello, G Valdiserra, ...
The Lancet Infectious Diseases 22 (11), e311-e326, 2022
2172022
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative …
RE Kast, JA Boockvar, A Brüning, F Cappello, WW Chang, B Cvek, ...
Oncotarget 4 (4), 502, 2013
2092013
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders
L Antonioli, R Colucci, C La Motta, M Tuccori, O Awwad, F Da Settimo, ...
Current drug targets 13 (6), 842-862, 2012
1942012
Convalescent plasma therapy for COVID-19: state of the art
D Focosi, AO Anderson, JW Tang, M Tuccori
Clinical microbiology reviews 33 (4), 10.1128/cmr. 00072-20, 2020
1602020
Cyclophosphamide-methotrexate ‘metronomic’chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation
G Bocci, M Tuccori, U Emmenegger, V Liguori, A Falcone, RS Kerbel, ...
Annals of oncology 16 (8), 1243-1252, 2005
1552005
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
M Tuccori, S Ferraro, I Convertino, E Cappello, G Valdiserra, C Blandizzi, ...
MAbs 12 (1), 1854149, 2020
1532020
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review
M Tuccori, A Testi, L Antonioli, M Fornai, S Montagnani, N Ghisu, ...
Clinical therapeutics 31, 1426-1453, 2009
1462009
COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current …
N Luxi, A Giovanazzi, A Capuano, S Crisafulli, PM Cutroneo, MP Fantini, ...
Drug safety 44 (12), 1247-1269, 2021
1402021
Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy
R Leone, L Magro, U Moretti, P Cutroneo, M Moschini, D Motola, ...
Drug safety 33, 667-675, 2010
1392010
Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications
L Antonioli, M Fornai, R Colucci, N Ghisu, M Tuccori, M Del Tacca, ...
Pharmacology & therapeutics 120 (3), 233-253, 2008
1382008
The impact of the COVID-19 “Infodemic” on drug-utilization behaviors: implications for pharmacovigilance
M Tuccori, I Convertino, S Ferraro, E Cappello, G Valdiserra, D Focosi, ...
Drug safety 43, 699-709, 2020
1002020
Progressive multifocal leukoencephalopathy and anti‐CD20 monoclonal antibodies: what do we know after 20 years of rituximab
D Focosi, M Tuccori, F Maggi
Reviews in medical virology 29 (6), e2077, 2019
1002019
Toxicities with immune checkpoint inhibitors: emerging priorities from disproportionality analysis of the FDA adverse event reporting system
E Raschi, A Mazzarella, IC Antonazzo, N Bendinelli, E Forcesi, M Tuccori, ...
Targeted oncology 14, 205-221, 2019
942019
ALK-1–negative anaplastic large cell lymphoma associated with breast implants: A new clinical entity
D Lazzeri, T Agostini, G Bocci, G Giannotti, G Fanelli, AG Naccarato, ...
Clinical Breast Cancer 11 (5), 283-296, 2011
942011
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting
M Tuccori, F Lapi, A Testi, E Ruggiero, U Moretti, A Vannacci, R Bonaiuti, ...
Drug safety 34, 849-859, 2011
912011
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage
M Fornai, G Natale, R Colucci, M Tuccori, G Carazzina, L Antonioli, ...
Naunyn-Schmiedeberg's archives of pharmacology 372, 79-87, 2005
912005
Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of …
M Fornai, R Colucci, L Antonioli, O Awwad, C Ugolini, M Tuccori, F Fulceri, ...
Pharmacological Research 63 (1), 59-67, 2011
872011
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases
L Antonioli, M Fornai, R Colucci, N Ghisu, M Tuccori, M Del Tacca, ...
Inflammatory bowel diseases 14 (4), 566-574, 2008
842008
Drug therapeutic failures in emergency department patients: a university hospital experience
A Franceschi, M Tuccori, G Bocci, F Vannozzi, A Di Paolo, C Barbara, ...
Pharmacological research 49 (1), 85-91, 2004
802004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20